A novel 5-[1,3,4-oxadiazol-2-yl]-N-aryl-4,6-pyrimidine diamine having dual EGFR/HER2 kinase activity: Design, synthesis, and biological activity - Concepedia

Concepedia

Publication | Open Access

A novel 5-[1,3,4-oxadiazol-2-yl]-N-aryl-4,6-pyrimidine diamine having dual EGFR/HER2 kinase activity: Design, synthesis, and biological activity

DOI Full Paper Access

27

Citations

6

References

2008

Year

Terry V. Hughes, Guozhang Xu, Steven K. Wetter, Peter J. Connolly, Stuart L. Emanuel, Prabha Karnachi, Scott R. Pollack, Niranjan B. Pandey, Mary Adams, Sandra Moreno-Mazza,

Bioorganic & Medicinal Chemistry Letters

Biological ActivityMedicinal ChemistryBiochemistryNatural SciencesMedicineMechanism Of ActionPharmacological AgentPharmacotherapyChemical BiologyPharmacologyPharmaceutical ChemistryDrug Discovery

References

	Year	Citations

Page 1

Page 1